Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cerus Corporation
A new report from Informa's Meddevicetracker highlights strong projected growth in the market, explaining the underlying reasons why.
Stock-and-cash deal valued at $229m brings AzurRx rights to niclosamide in additional indications. Boehringer Ingelheim partners with Twist on therapeutic antibody discovery.
Citing the pandemic, the US Centers for Medicare & Medicaid Services (CMS) discounted 2020 data in reviewing renewals for New Technology Add-On Payment (NTAP) status and granted extensions through 30 September to 13 NTAP products.
FDA grants emergency use authorization to OTC COVID-19 testing products as it targets allowing workplaces, schools and communities to access tools needed to screen for the virus rapidly and accurately.
- Infection Control-Sterilization